Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Alpha Cognition receives notice of allowance for US patent of novel AD drug
A Vancouver-based biopharmaceutical company has secured a notice of allowance, presaging a U.S. patent for a crystalline formulation of a novel acetylcholinesterase inhibitor to treat Alzheimer’s disease.
Study: Dementia diagnosed later in Parkinson’s disease course
In two large trials of individuals with Parkinson’s disease, dementia occurred less frequently and later in the disease course than previously thought, according to new research published in Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s risk altered by late-life high BP, antihypertensive treatment
Treating high blood pressure later in life may mitigate risk for developing Alzheimer’s disease among older individuals, according to a meta-analysis published in Neurology.
Severe menopause symptoms linked to cognitive impairment in later life
Severe menopause symptoms, such as hot flashes and depressive mood, were associated with mild cognitive impairment for postmenopausal women, researchers reported in Menopause.
Podcast featuring guides for dementia-related issues received favorably
PHILADELPHIA — A podcast that offers guidance for living with dementia as well as a space for those with lived experience to share their stories has received favorable reviews, according to a poster.
VIDEO: Computerized test detects cognitive impairment, amyloid presence in preclinical AD
PHILADELPHIA — A computerized cognitive battery was effective in detecting cognitive impairment and amyloid presence in preclinical Alzheimer’s disease, James E. Galvin, MD, MPH, said in this Healio Video Perspective.
Recombinant shingles vaccine linked to reduced risk for dementia
Adults who received the recombinant zoster vaccine had a significantly lower risk for dementia over the next 6 years compared with live vaccine recipients, study results published in Nature Medicine revealed.
VIDEO: Phosphorylated tau assays most accurate in identifying amyloid PET status
PHILADELPHIA — In this Healio Video Perspective, Suzanne E. Schindler, MD, PhD, revealed phosphorylated tau biomarker assays were most accurate in identifying amyloid positron emission tomography status in Alzheimer’s disease.
Dementia diagnosis rates 4% lower for Medicare Advantage enrollees
PHILADELPHIA — An analysis of more than 15 million Americans enrolled in Medicare found that those enrolled in the Medicare Advantage plan had a 4% lower dementia diagnosis rate than those in traditional Medicare, according to a presenter.
Spending less time in HbA1c target range may increase dementia risk for older adults
Older adults with diabetes who spend less time within their individualized HbA1c target range have a higher risk for developing Alzheimer’s disease and dementias, according to findings published in JAMA Network Open.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read